Last reviewed · How we verify

NCT03231787: AFFEcT

Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery

Completed NA Last updated 19 January 2023
What this trial tests

NA trial testing Platelet function assay in Femur Fracture in 156 participants. Completed in 17 December 2021.

Timeline
4 September 2017
Primary endpoint
17 November 2021
17 December 2021

Quick facts

Lead sponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment156
Start date4 September 2017
Primary completion17 November 2021
Estimated completion17 December 2021
Sites3 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Who can join

18 and older, any sex, with Femur Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

National, randomized, open, parallel, multicenter clinical trial of two comparison groups that will evaluate the feasibility of a strategy based on a diagnostic test to shorten the surgery time in antiaggregated patients with proximal femur fracture. The experimental group will undergo surgery as soon as platelet aggregability, according to the PLATELETWORKS® method is correct within 24-48 hours. The control group will undergo surgery according to the usual practice of the center taking into account the safety time of the antiplatelet agent.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Evaluation of a strategy to shorten the time to surgery in patients on antiplatelet therapy with a proximal femur fracture (AFFEcT Study): Study protocol for a multicenter randomized controlled clinical trial.
    Rafael A, Mireia R, José María G, Victoria M, et al · · 2019 · cited 5× · PMID 31083195 · DOI 10.1097/md.0000000000015514
  2. Early Surgery with Neuraxial Anaesthesia in Patients on Chronic Antiplatelet Therapy with a Proximal Femur Fracture: Multicentric Randomised Clinical Trial.
    Anaya R, Rodriguez M, Millan A, Reguant F, et al · · 2021 · cited 3× · PMID 34830654 · DOI 10.3390/jcm10225371
  3. Correlation between PlateletWorks<sup>®</sup> and PFA-100<sup>®</sup> for Measuring Platelet Function before Urgent Surgery in Patients with Chronic Antiplatelet Therapy.
    Anaya R, Rodriguez M, Gil JM, Vilalta N, et al · · 2021 · cited 2× · PMID 33445597 · DOI 10.3390/jcm10020255
  4. Quality of Life and Post-Surgical Complications in Patients on Chronic Antiplatelet Therapy with Proximal Femur Fracture: 12-Month Follow-Up after Implementing a Strategy to Shorten the Time to Surgery.
    Merchán-Galvis A, Anaya R, Rodriguez M, Llorca J, et al · · 2023 · cited 1× · PMID 36769778 · DOI 10.3390/jcm12031130

Verify or expand the search:

Other trials of Platelet function assay

Trials testing the same drug.

Other recruiting trials for Femur Fracture

Currently open trials in the same condition.

Other Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03231787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing